Hsbc Holdings PLC Vertex Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

A detailed history of Hsbc Holdings PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 805,942 shares of VRTX stock, worth $382 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

805,942

Previous 614,669 31.12%

Holding current value

$382 Million

Previous $250 Million 34.7%

% of portfolio

0.23%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $78 Million - $85.3 Million	191,273 Added 31.12%	805,942 $337 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $18.5 Million - $22.1 Million	53,862 Added 9.6%	614,669 $250 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $41.1 Million - $44 Million	-121,386 Reduced 17.79%	560,807 $195 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $37.4 Million - $41.8 Million	118,878 Added 21.1%	682,193 $240 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $21.2 Million - $24.1 Million	74,725 Added 15.29%	563,315 $177 Million

Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $50.5 Million - $56.8 Million	176,722 Added 56.67%	488,590 $141 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $5.17 Million - $5.77 Million	-18,892 Reduced 5.71%	311,868 $90.9 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $4.1 Million - $5.11 Million	-17,468 Reduced 5.02%	330,760 $93.2 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $6.86 Million - $8.09 Million	-30,985 Reduced 8.17%	348,228 $90.5 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $3.87 Million - $4.88 Million	-21,846 Reduced 5.45%	379,213 $83.3 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $7.78 Million - $8.71 Million	42,914 Added 11.98%	401,059 $72.9 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $10.6 Million - $12.5 Million	56,678 Added 18.8%	358,145 $72.2 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $12.1 Million - $14.1 Million	-58,268 Reduced 16.2%	301,467 $64.8 Million
Q4 2020 Feb 25, 2021	SELL	$207.01 - $276.09 $6.19 Million - $8.26 Million	-29,900 Reduced 7.67%	359,735 $85 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $18.8 Million - $25.1 Million	90,971 Added 30.46%	389,635 $92.1 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $19.1 Million - $22.6 Million	74,598 Added 33.29%	298,664 $81.3 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $672,606 - $882,371	-2,983 Reduced 1.31%	224,066 $65 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $3.34 Million - $4.14 Million	16,710 Added 7.94%	227,049 $53.5 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $10.7 Million - $14.3 Million	-64,040 Reduced 23.34%	210,339 $47 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $3.76 Million - $4.23 Million	22,616 Added 8.98%	274,379 $46.5 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $15.4 Million - $17.9 Million	93,849 Added 59.43%	251,763 $46.2 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $2.12 Million - $2.52 Million	12,924 Added 8.91%	157,914 $29 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $10.2 Million - $12.9 Million	-66,863 Reduced 31.56%	144,990 $23.8 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $2.98 Million - $3.43 Million	17,772 Added 9.16%	211,853 $40.8 Million
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $12.7 Million - $14.8 Million	-86,920 Reduced 30.93%	194,081 $33 Million
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $4.4 Million - $5.15 Million	29,050 Added 11.53%	281,001 $45.8 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $8.44 Million - $9.56 Million	-61,476 Reduced 19.61%	251,951 $37.8 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $8.54 Million - $9.36 Million	57,668 Added 22.55%	313,427 $47.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	255,759	255,759 $33 Million

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Vertex Pharmaceuticals Inc Transaction History